Society for Clinical Research Sites Welcomes Covance as its Newest Global Impact Partner
Ellicott City, M.D., June 23, 2015 – The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, today announced a two-year partnership with Laboratory Corporation of America® Holdings (LabCorp®) (LH: NYSE). Under the agreement, Covance Drug Development (Covance) will participate as a Global Impact Partner (GIP), a relationship designed to facilitate critical dialogue between industry stakeholders and clinical research sites.
“Covance’s commitment to partner with SCRS as a GIP demonstrates that establishing positive site relationships is a high priority for them,” commented Christine Pierre, SCRS President. “SCRS’ GIPs are focused on acknowledging the realities that today’s sites face, and actively addressing their challenges. SCRS is proud to welcome Covance as our newest Global Impact Partner.”
“Covance is committed to serving the clinical research community as a strong scientific partner in order to speed the development of innovative medicines that meet today’s global healthcare needs,” said Jill Johnston, Global Vice President, Site Activation, Informatics and Optimization, Covance. “Our work with SCRS will help us better understand the needs of our clinical research partners and ultimately improve service to our pharmaceutical and biotechnology clients.”
As a GIP, Covance will participate on the SCRS Global Impact Board at an executive level, and work in tandem with SCRS’ Leadership Council in the development and execution of strategic initiatives for SCRS.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
